Share class: Tactile Systems Technology, Inc.

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 23,997,089 23,528,504 ( 98.05 %) 0 98.05 %

Major shareholders: Tactile Systems Technology, Inc.

NameEquities%Valuation
Eaton Vance Management
10.27 %
2,293,120 10.27 % 67 M $
Cadian Capital Management LP
9.204 %
2,055,758 9.204 % 60 M $
BlackRock Advisors LLC
7.548 %
1,685,915 7.548 % 49 M $
Vanguard Fiduciary Trust Co.
7.393 %
1,651,170 7.393 % 48 M $
Paradigm Capital Management, Inc.
6.888 %
1,538,400 6.888 % 45 M $
DFA Australia Ltd.
5.138 %
1,147,587 5.138 % 33 M $
Dimensional Fund Advisors LP
4.904 %
1,095,235 4.904 % 32 M $
Capitolis Liquid Global Markets LLC
4.039 %
902,062 4.039 % 26 M $
Acadian Asset Management LLC
3.785 %
845,448 3.785 % 25 M $
DWS Investment Management Americas, Inc.
2.584 %
577,187 2.584 % 17 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional92%
Individuals4%
Other3.17%
State Street Corp.2.3%
Governments0.05%
Baader Bank AG0.03%

Based on 1000 largest holdings

Geographical origin of shareholders

United States
90.17%
Australia
5.14%
Individuals
4%
Germany
0.73%
Norway
0.65%
United Kingdom
0.51%
Ireland
0.2%
France
0.12%
Canada
0.02%
Netherlands
0.01%

Based on 1000 largest holdings

Logo Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
Employees
1,037
More about the company